Revenue (Tables)

12 Months Ended

Dec. 31, 2018

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]

The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):

	Year Ended December 31,
Businesses	2018		2017		2016
Endoscopy
U.S.	$	980	$	894	$	770
International	781		724		670
Worldwide	1,762		1,619		1,440
Urology and Pelvic Health
U.S.	864		785		711
International	381		339		294
Worldwide	1,245		1,124		1,005
Cardiac Rhythm Management
U.S.	1,159		1,135		1,110
International	792		760		740
Worldwide	1,951		1,895		1,850
Electrophysiology
U.S.	150		136		129
International	161		142		114
Worldwide	311		278		243
Neuromodulation
U.S.	624		517		474
International	155		118		82
Worldwide	779		635		556
Interventional Cardiology
U.S.	1,154		1,122		1,013
International	1,436		1,297		1,268
Worldwide	2,590		2,419		2,281
Peripheral Interventions
U.S.	608		575		552
International	579		506		459
Worldwide	1,187		1,081		1,011
Total Company
U.S.	5,538		5,162		4,759
International	4,286		3,885		3,627
Net Sales	$	9,823	$	9,048	$	8,386

	Year Ended December 31,
Geographic Regions	2018		2017		2016
U.S.	$	5,538	$	5,162	$	4,759
EMEA (Europe, Middle East and Africa)	2,176		1,940		1,802
APAC (Asia-Pacific)	1,727		1,587		1,492
LACA (Latin America and Canada)	383		358		333
	$	9,823	$	9,048	$	8,386
Emerging Markets (1)	$	1,072	$	909	$	793

(1) Emerging Markets is defined as certain countries that we believe have strong growth potential based on their economic conditions, healthcare sectors and our global capabilities. Currently, we include 20 countries in our definition of Emerging Markets.